Partisil® and Partisphere® HPLC column ranges acquired by Hichrom from Whatman/GE Healthcare
Hichrom Limited are pleased to announce the acquisition of the Partisil® and Partisphere® HPLC column consumable product line from Whatman, a division of GE Healthcare. Based in the UK, Hichrom are a leading European manufacturer and distributor of HPLC columns, consumables and media, with manufacturing facilities accredited to both ISO9001 (Quality) and ISO14001 (Environmental) standards.
Hichrom Limited are pleased to announce the acquisition of the Partisil® and Partisphere® HPLC column consumable product line from Whatman, a division of GE Healthcare. Based in the UK, Hichrom are a leading European manufacturer and distributor of HPLC columns, consumables and media, with manufacturing facilities accredited to both ISO9001 (Quality) and ISO14001 (Environmental) standards.
Hichrom have worked closely with GE Healthcare during the manufacture of these products for a number of years, and as such manufacturing protocols, product specifications and part numbers will remain unaffected by the acquisition.
Additionally, Hichrom are pleased to confirm that Partisil and Partisphere column pricing will remain unchanged from the current GE Healthcare US List Price.
Until 16th April 2012, please continue to order these products as usual from GE Healthcare or their appointed distributors.
From 17th April 2012, Partisil and Partisphere products will no longer be available from GE Healthcare, and customers are requested to contact Hichrom directly to confirm their local distributor.
For further information on the acquisition of the Partisil and Partisphere HPLC column consumable product line please visit www.partisil.com
For details of Hichrom’s full range of HPLC products please visit ref="http://www.hichrom.co.uk">www.hichrom.co.uk
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Metabolomics Analysis of Low Birth-Weight Infants Using UHPLC-MS/MS Following Lipid Emulsion
January 10th 2025A recent study aimed to directly compare the changes in serum metabolites among very low birth-rate (VLBW) infants following the administration of the soybean oil-based lipid emulsion and soybean oil, medium-chain triglycerides, olive oil, and fish oil (SMOF) lipid emulsion using untargeted metabolomics techniques.
Analyzing New Drug Modalities: An ISC 2024 Interview with Kelly Zhang
January 10th 2025At ISC 2024 in Liverpool, United Kingdom, LCGC International interviewed Kelly Zhang of Genentech about her work analyzing new drug modalities, such as mRNA, oligonucleotides, peptides, and cell and gene therapies.
